US Tech 100

18,722.80

-0.19%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SNY

Sanofi (SNY)

Sanofi

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:SNY

1 2 3 4 5 6 7 8 9 10 Next >>

Date	Time	Source	Headline	Symbol	Company
03/28/2025	2:00AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved as the First-ever Biologic Medicine in Japan for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
03/27/2025	1:39PM	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:SNY	Sanofi
03/26/2025	11:56AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
03/21/2025	6:04AM	Edgar (US Regulatory)	Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments	NASDAQ:SNY	Sanofi
03/20/2025	11:06AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
03/14/2025	2:18PM	PR Newswire (US)	Sanofi adopts FDA-selected flu strains to ensure readiness for the 2025-26 flu season	NASDAQ:SNY	Sanofi
03/10/2025	12:23PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
03/08/2025	1:00PM	GlobeNewswire Inc.	Dupixent® (dupilumab) Late-Breaking Positive Pivotal Data in Bullous Pemphigoid Presented at AAD	NASDAQ:SNY	Sanofi
02/22/2025	2:20AM	GlobeNewswire Inc.	Teva and Sanofi Present New Positive Phase 2b Study Results at ECCO 2025 Reinforcing Best-in-Class Potential of Duvakitug (Anti-TL1A) in Ulcerative Colitis and Crohn’s Disease	NASDAQ:SNY	Sanofi
02/13/2025	2:11PM	Edgar (US Regulatory)	Form IRANNOTICE - Notice of disclosure filed pursuant to Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 (Exchange Act Section 13(r)).	NASDAQ:SNY	Sanofi
02/13/2025	1:41PM	Edgar (US Regulatory)	Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]	NASDAQ:SNY	Sanofi
02/13/2025	12:23PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
02/03/2025	12:14PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
01/30/2025	9:50AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
12/13/2024	11:07AM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
11/18/2024	12:23PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi
11/15/2024	12:59AM	GlobeNewswire Inc.	Dupixent® (dupilumab) sBLA Accepted for FDA Review for the Treatment of Chronic Spontaneous Urticaria (CSU)	NASDAQ:SNY	Sanofi
11/06/2024	1:00AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the European Union as the First and Only Medicine for Young Children with Eosinophilic Esophagitis	NASDAQ:SNY	Sanofi
10/28/2024	5:56PM	PR Newswire (Canada)	L'immunisation par Beyfortus® pour protéger les nourrissons contre le VRS a commencé	NASDAQ:SNY	Sanofi
10/28/2024	5:54PM	PR Newswire (Canada)	Beyfortus® immunization to protect infants from RSV has begun	NASDAQ:SNY	Sanofi
10/25/2024	6:05AM	IH Market News	Capri Shares Crash 45% After Merger Block; Coursera Falls 18% on Lower Revenue Forecast	NASDAQ:SNY	Sanofi
10/21/2024	5:47AM	IH Market News	Spirit’s Stock Surges 56% on Refinancing; Starboard Invests in Kenvue; Cigna-Humana Merger Back in Negotiations	NASDAQ:SNY	Sanofi
10/17/2024	2:35AM	Business Wire	Sanofi et Orano Med unissent leurs forces pour développer des radiothérapies internes vectorisées de nouvelle génération	NASDAQ:SNY	Sanofi
10/17/2024	2:35AM	Business Wire	Sanofi and Orano Join Forces to Develop Next-generation Radioligand Medicines	NASDAQ:SNY	Sanofi
10/16/2024	12:26PM	PR Newswire (US)	FLUBLOK® (Influenza Vaccine) US label updated with one of Sanofi's largest flu vaccine safety studies in pregnant individuals	NASDAQ:SNY	Sanofi
10/16/2024	6:00AM	PR Newswire (US)	Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies	NASDAQ:SNY	Sanofi
10/11/2024	6:31AM	IH Market News	BP Signals Rising Net Debt; Tesla Slumps; Stellantis CEO Announces Retirement; Berkshire Trims BofA Stake, and More	NASDAQ:SNY	Sanofi
09/27/2024	9:35AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in the U.S. as the First-ever Biologic Medicine for Patients with COPD	NASDAQ:SNY	Sanofi
09/27/2024	7:00AM	GlobeNewswire Inc.	Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)	NASDAQ:SNY	Sanofi
09/24/2024	2:51PM	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:SNY	Sanofi